09:31:32 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-14 Kvartalsrapport 2024-Q3
2024-08-23 Kvartalsrapport 2024-Q2
2024-05-03 Kvartalsrapport 2024-Q1
2024-03-15 Ordinarie utdelning ALK B 0.00 DKK
2024-03-14 Årsstämma 2024
2024-02-08 Bokslutskommuniké 2023
2023-11-15 Kvartalsrapport 2023-Q3
2023-08-24 Kvartalsrapport 2023-Q2
2023-05-09 Kvartalsrapport 2023-Q1
2023-03-20 Ordinarie utdelning ALK B 0.00 DKK
2023-02-03 Bokslutskommuniké 2022
2022-11-10 Kvartalsrapport 2022-Q3
2022-08-11 Kvartalsrapport 2022-Q2
2022-05-12 Kvartalsrapport 2022-Q1
2022-03-28 Split ALK B 1:20
2022-03-17 Ordinarie utdelning ALK B 0.00 DKK
2022-03-16 Årsstämma 2022
2022-02-08 Bokslutskommuniké 2021
2021-11-11 Kvartalsrapport 2021-Q3
2021-08-11 Kvartalsrapport 2021-Q2
2021-05-05 Kvartalsrapport 2021-Q1
2021-03-19 Ordinarie utdelning ALK B 0.00 DKK
2021-03-18 Årsstämma 2021
2021-02-10 Bokslutskommuniké 2020
2020-11-11 Kvartalsrapport 2020-Q3
2020-08-12 Kvartalsrapport 2020-Q2
2020-05-06 Kvartalsrapport 2020-Q1
2020-03-12 Ordinarie utdelning ALK B 0.00 DKK
2020-03-11 Årsstämma 2020
2020-02-05 Bokslutskommuniké 2019
2019-11-07 Kvartalsrapport 2019-Q3
2019-08-13 Kvartalsrapport 2019-Q2
2019-05-09 Kvartalsrapport 2019-Q1
2019-03-14 Ordinarie utdelning ALK B 0.00 DKK
2019-03-13 Årsstämma 2019
2019-02-07 Bokslutskommuniké 2018
2018-11-09 Kvartalsrapport 2018-Q3
2018-08-15 Kvartalsrapport 2018-Q2
2018-05-04 Kvartalsrapport 2018-Q1
2018-03-13 Ordinarie utdelning ALK B 0.00 DKK
2018-03-12 Årsstämma 2018
2018-02-06 Bokslutskommuniké 2017
2017-11-10 Kvartalsrapport 2017-Q3
2017-08-16 Kvartalsrapport 2017-Q2
2017-05-09 Kvartalsrapport 2017-Q1
2017-03-16 Ordinarie utdelning ALK B 5.00 DKK
2017-03-15 Årsstämma 2017
2017-02-07 Bokslutskommuniké 2016
2016-11-10 Kvartalsrapport 2016-Q3
2016-08-16 Kvartalsrapport 2016-Q2
2016-05-04 Kvartalsrapport 2016-Q1
2016-03-11 Ordinarie utdelning ALK B 5.00 DKK
2016-03-10 Årsstämma 2016
2016-02-09 Bokslutskommuniké 2015
2015-11-12 Kvartalsrapport 2015-Q3
2015-08-18 Kvartalsrapport 2015-Q2
2015-05-05 Kvartalsrapport 2015-Q1
2015-03-13 Ordinarie utdelning ALK B 5.00 DKK
2015-03-12 Årsstämma 2015
2015-02-09 Bokslutskommuniké 2014
2014-11-14 Kvartalsrapport 2014-Q3
2014-08-13 Kvartalsrapport 2014-Q2
2014-05-08 Kvartalsrapport 2014-Q1
2014-03-13 Ordinarie utdelning ALK B 5.00 DKK
2014-03-12 Årsstämma 2014
2014-02-05 Bokslutskommuniké 2013
2013-11-08 Kvartalsrapport 2013-Q3
2013-08-14 Kvartalsrapport 2013-Q2
2013-05-03 Kvartalsrapport 2013-Q1
2013-03-13 Ordinarie utdelning ALK B 5.00 DKK
2013-03-12 Årsstämma 2013
2013-02-05 Bokslutskommuniké 2012
2012-11-12 Kvartalsrapport 2012-Q3
2012-08-16 Kvartalsrapport 2012-Q2
2012-05-10 Kvartalsrapport 2012-Q1
2012-03-28 Ordinarie utdelning ALK B 5.00 DKK
2012-03-27 Årsstämma 2012
2012-02-22 Bokslutskommuniké 2011
2011-11-11 Kvartalsrapport 2011-Q3
2011-08-16 Kvartalsrapport 2011-Q2
2011-05-10 Kvartalsrapport 2011-Q1
2011-04-04 Ordinarie utdelning ALK B 5.00 DKK
2011-04-01 Årsstämma 2011
2010-03-29 Ordinarie utdelning ALK B 5.00 DKK

Beskrivning

LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriMedicinteknik
AlK-Abelló är verksamma inom läkemedelsbranschen. Bolaget är en utvecklare av allergi- och immunterapi. Verksamhet innehas på global nivå och produkterna säljs både som vaccin och i tablettform. En stor del av verksamheten fokuserar mot forskning och utveckling inom nämnt arbetsområde, där bolaget aktivt arbetar med diagnostisering och behandling av återkommande allergibesvär. Bolaget grundades 1923 och har sitt huvudkontor i Hørsholm.
2022-03-24 17:15:00

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF):

Share option programme
According to the Company’s remuneration policy which was adopted at the Company's Annual General Meeting on 18 March 2021, in line with its usual practice, the Board of Directors has passed a resolution to grant a total of 9,965 share options, comprising 5,002 options to the members of the Board of Management and 4,963 options to a group of key employees. As is the norm, the share option programme is subject to the fulfilment of financial and non-financial key indicators with a defined threshold, below which there would be no payout, and which also offers the opportunity to perform above target. As in previous years, in case of performance above target, a defined multiplier is used that can increase the payout by up to 100%.

The options can be exercised during the period from 1 March 2025 to 1 March 2027 during the trading windows following the release of annual and interim reports. If the option holders have not exercised their options within the period specified, the options will lapse without any compensation to the holders.

Performance share programme
The exercise price of the options has been set at DKK 2,819 each, corresponding to an average of the closing prices of the Company’s shares on Nasdaq Copenhagen during the period 17 to 23 March 2022 (both days included). To this should be added annual interest at the rate of 2.5%, which will be added the first time on 1 March 2023. The exercise price of the options will be adjusted by dividends if dividends deviate from DKK 0 per share.

The market value of the adopted option plan of 9,965 options is approximately DKK 6.7 million applying the Black & Scholes model for valuation of options. The determination of the value is based on an assumed exercise price of DKK 3,036, an annual dividend distribution of DKK 0 per share, a volatility rate of 35% p.a. and a risk-free interest rate of 0.14% p.a.

Under the international financial reporting standards (IFRS), the incentive plan will be recognised in the income statement in the respective functional areas over the vesting period.

Further in line with its usual practice, the Board of Directors has passed a resolution to grant performance shares in accordance with the Company’s remuneration policy, and which was also adopted at the Company's Annual General Meeting on 18 March 2021. The scheme, which is a long-standing component of performance management at ALK, comprises a total of 7,261 performance shares, including 1,186 shares to the members of the Board of Management and 6,075 shares to a group of key employees. The market value of the performance shares is approximately DKK 20.5 million, calculated on the basis of an average of the closing prices of the Company's shares on Nasdaq Copenhagen during the period 17 to 23 March 2022 (both days included).

The final transfer of ownership of the performance shares takes place three years after the grant (2025), and is subject to the fulfilment of financial and non-financial key indicators with a threshold below which there will be no payout, and with the opportunity to perform above target. In case of performance above target, a defined multiplier is used that can increase the payout by up to 100%.

Under the international financial reporting standards (IFRS), the incentive plan will be recognised in the income statement in the respective functional areas over the vesting period.

The grant of share options and performance shares does not change the Company’s financial forecast.

No share options or performance shares have been granted to members of the Board of Directors.

ALK-Abelló A/S

For further information please contact:

Anders Hedegaard, Chairman of the Board of Directors, tel +45 4574 7576